BioFluidica

About BioFluidica

BioFluidica is a privately held biotechnology company specializing in advanced diagnostic solutions for early disease detection and monitoring. Operating in the healthcare and biotechnology markets, BioFluidica serves medical professionals, research institutions, and healthcare providers. The company's core product is a diagnostic platform that utilizes liquid biopsy technology to capture and isolate disease biomarkers, such as Circulating Tumor Cells (CTCs), from a simple blood test. This platform offers high-throughput access to cancer cells and their information, enabling precise disease management and diagnosis. BioFluidica's business model revolves around selling its diagnostic platform and related services to healthcare providers and research institutions, generating revenue through product sales and service contracts. The company aims to reduce the need for invasive tissue biopsies, providing a more comprehensive and less invasive diagnostic alternative.